Mechanisms of alloimmunization and subsequent bone marrow transplantation rejection induced by platelet transfusion in a murine model

American Journal of Transplantation

Volumn 12, Issue 5, 2012, Pages 1102-1112

  Patel, S R ^a   Smith, N H ^a   Kapp, L ^a   Zimring, J C ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Bone marrow transplantation; minor antigens; platelet; T cells; transfusion

Indexed keywords

ALLOANTIGEN;

ALLOIMMUNITY; ALLOIMMUNIZATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DISEASE MODEL; FEMALE; GRAFT REJECTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; THROMBOCYTE TRANSFUSION;

ANIMALS; BLOOD PLATELETS; BONE MARROW DISEASES; BONE MARROW TRANSPLANTATION; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; GRAFT REJECTION; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MICE; MICE, INBRED BALB C; PLATELET TRANSFUSION; TRANSPLANTATION, HOMOLOGOUS;

EID: 84860437959     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2011.03959.x     Document Type: Article

References (25)

1. Bhatia M, Walters MC,. Hematopoietic cell transplantation for thalassemia and sickle cell disease: Past, present and future. Bone Marrow Transplant 2008; 41: 109-117.
2. Horan JT, Liesveld JL, Fenton P, Blumberg N, Walters MC,. Hematopoietic stem cell transplantation for multiply transfused patients with sickle cell disease and thalassemia after low-dose total body irradiation, fludarabine, and rabbit anti-thymocyte globulin. Bone Marrow Transplant 2005; 35: 171-177.
3. Marsh JC, Ball SE, Darbyshire P, et al,. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol 2003; 123: 782-801.
4. Or R, Aker M, Shapira MY, et al,. Allogeneic stem cell transplantation for the treatment of diseases associated with a deficiency in bone marrow products. Springer Semin Immunopathol 2004; 26: 133-142.
5. Wagner JE, Eapen M, MacMillan ML, et al,. Unrelated donor bone marrow transplantation for the treatment of Fanconi anemia. Blood 2007; 109: 2256-2262.
6. Resnick IB, Shapira MY, Slavin S,. Nonmyeloablative stem cell transplantation and cell therapy for malignant and non-malignant diseases. Transpl Immunol 2005; 14: 207-219.
7. Srinivasan R, Takahashi Y, McCoy JP, et al,. Overcoming graft rejection in heavily transfused and allo-immunised patients with bone marrow failure syndromes using fludarabine-based haematopoietic cell transplantation. Br J Haematol 2006; 133: 305-314.
8. Champlin RE, Perez WS, Passweg JR, et al,. Bone marrow transplantation for severe aplastic anemia: A randomized controlled study of conditioning regimens. Blood 2007; 109: 4582-4585.
9. Viollier R, Socie G, Tichelli A, et al,. Recent improvement in outcome of unrelated donor transplantation for aplastic anemia. Bone Marrow Transplant 2008; 41: 45-50.
10. Deeg HJ, Self S, Storb R, et al,. Decreased incidence of marrow graft rejection in patients with severe aplastic anemia: Changing impact of risk factors. Blood 1986; 68: 1363-1368.
11. Gluckman E, Horowitz MM, Champlin RE, et al,. Bone marrow transplantation for severe aplastic anemia: Influence of conditioning and graft-versus-host disease prophylaxis regimens on outcome. Blood 1992; 79: 269-275.
12. Storb R, Thomas ED, Buckner CD, et al,. Marrow transplantation in thirty "untransfused" patients with severe aplastic anemia. Ann Intern Med 1980; 92: 30-36.
13. Champlin RE, Horowitz MM, van Bekkum DW, et al,. Graft failure following bone marrow transplantation for severe aplastic anemia: Risk factors and treatment results. Blood 1989; 73: 606-613.
14. Stucki A, Leisenring W, Sandmaier BM, Sanders J, Anasetti C, Storb R,. Decreased rejection and improved survival of first and second marrow transplants for severe aplastic anemia (a 26-year retrospective analysis). Blood 1998; 92: 2742-2749.
15. Patel SR, Cadwell CM, Medford A, Zimring JC,. Transfusion of minor histocompatibility antigen-mismatched platelets induces rejection of bone marrow transplants in mice. J Clin Invest 2009; 119: 2787-2794.
16. Ehst BD, Ingulli E, Jenkins MK,. Development of a novel transgenic mouse for the study of interactions between CD4 and CD8 T cells during graft rejection. Am J Transplant 2003; 3: 1355-1362.
17. Hogquist KA, Jameson SC, Heath WR, Howard JL, Bevan MJ, Carbone FR,. T cell receptor antagonist peptides induce positive selection. Cell 1994; 76: 17-27.
18. Kitamura D, Roes J, Kuhn R, Rajewsky K,. A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene. Nature 1991; 350: 423-426.
19. Zimmerman ZF, Levy RB,. MiHA reactive CD4 and CD8 T-cells effect resistance to hematopoietic engraftment following reduced intensity conditioning. Am J Transplant 2006; 6: 2089-2098.
20. Bevan MJ,. Helping the CD8(+) T-cell response. Nat Rev Immunol 2004; 4: 595-602.
21. Taylor PA, Ehrhardt MJ, Roforth MM, et al,. Preformed antibody, not primed T cells, is the initial and major barrier to bone marrow engraftment in allosensitized recipients. Blood 2007; 109: 1307-1315.
22. Xu H, Chilton PM, Tanner MK, et al,. Humoral immunity is the dominant barrier for allogeneic bone marrow engraftment in sensitized recipients. Blood 2006; 108: 3611-3619.
23. Gilson CR, Zimring JC,. Alloimmunization to transfused platelets requires priming of CD4+ T cells in the splenic microenvironment in a murine model. Transfusion 2011; in press. doi:.
24. Rozman P,. Platelet antigens. The role of human platelet alloantigens (HPA) in blood transfusion and transplantation. Transpl Immunol 2002; 10: 165-181.
25. Chan KW, Li CK, Worth LL, et al,. A fludarabine-based conditioning regimen for severe aplastic anemia. Bone Marrow Transplant 2001; 27: 125-128.